BiotechTube
Home/Pipeline/Next-Gen US-guided HIFU Therapy System

Next-Gen US-guided HIFU Therapy System

Pancreatic Cancer

PreclinicalDevelopment

Key Facts

Indication
Pancreatic Cancer
Phase
Preclinical
Status
Development
Company
SONIRE Therapeutics

About SONIRE Therapeutics

Developing a cavitation-enhanced, ultrasound-guided HIFU therapy system for minimally invasive treatment of intractable cancers, starting with pancreatic cancer.

View full company profile

Therapeutic Areas

Oncology

Other Pancreatic Cancer Drugs

DrugCompanyPhase
Ampligen® (rintatolimod)AIM ImmunoTechEarly Access Program
HBM9027Harbour BioMedPhase 1
Small-Molecule TherapeuticAIkido LabsPre-clinical
AHPBA IRE RegistryAngioDynamicsPost-Market Registry
SIMBs + ImmunotherapyAdvanced MicrobubblesPre-clinical
CLS-014CLS TherapeuticsPre-clinical
SOMA PlatformCoherence NeuroPre-clinical
NP-G2-044Novita PharmaceuticalsPhase 2a
Pritumumab (PTB)Nascent BiotechPhase II (Planned)
Pancreatic Cancer TestMosaique DiagnosticDevelopment
Iontophoretic SystemContinuity BiosciencesPre-clinical
Lixumistat (IM156)ImmunoMet TherapeuticsPhase 1b